Always consult a qualified clinician to review your medical history, medications, and risks before starting injections or prescription weight-loss medications
Journal of Clinical Psychopharmacology, 24(1), 4-10
Assessment and monitoring: Be vigilant for signs that your diabetes management may be affected, including: Elevated blood glucose readings above your usual range Increased thirst or urination (signs of hyperglycaemia) Unusual fatigue or lack of energy Return of symptoms that were previously well-controlled If you experience severe symptoms such as persistent vomiting, severe abdominal pain, or signs of pancreatitis (rare but serious), seek urgent medical attention from your GP, NHS 111, or 999 as appropriate
In clinical trials for adults for weight reduction, severe gastrointestinal adverse reactions were reported more frequently among patients receiving WEGOVY than placebo
Clinical Benefits Recent studies have illustrated the substantial benefits of Semaglutide, suggesting it can lead to: Significant Reductions in HbA1c: Clinical trials show that Semaglutide effectively lowers HbA1c, providing patients with improved long-term glucose control
